You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Harman Finochem Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HARMAN FINOCHEM, and what generic and branded alternatives to HARMAN FINOCHEM drugs are available?

HARMAN FINOCHEM has five approved drugs.

Summary for Harman Finochem

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	5

Drugs and US Patents for Harman Finochem

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Harman Finochem	THEOPHYLLINE	theophylline	TABLET, EXTENDED RELEASE;ORAL	214806-002	Oct 24, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	ALLOPURINOL	allopurinol	TABLET;ORAL	214443-001	Mar 7, 2022	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	218673-001	Jul 5, 2024	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	ALLOPURINOL	allopurinol	TABLET;ORAL	214443-002	Mar 7, 2022	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	BISOPROLOL FUMARATE	bisoprolol fumarate	TABLET;ORAL	217617-002	Jan 18, 2024	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	213320-002	Dec 3, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Harman Finochem	THEOPHYLLINE	theophylline	TABLET, EXTENDED RELEASE;ORAL	214806-001	Oct 24, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.